Sanofi (SNY) Q4 Earnings Top, Genzyme Unit Drives Sales Growth

Sanofi SNY reported fourth-quarter 2018 earnings of 63 cents per American depositary share, which beat the Zacks Consensus Estimate of 61 cents. Earnings increased 3.8% on a reported basis. At constant currency rates (CER), earnings grew 4.7%, driven by strong top-line growth and a reduced share count.